发明名称 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
摘要 The present invention relates to methods and pharmaceutical compositions for the treatment of cancer. In particular, the present invention relates to a polypeptide comprising or consisting of i) an amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO: 1 or, ii) an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO: 1, or iii) an amino acid sequence which is a retro-inverso of the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO: 1 or, iv) an amino acid sequence which is retro-inverso of the amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO: 1.
申请公布号 US2017058010(A1) 申请公布日期 2017.03.02
申请号 US201515119274 申请日期 2015.02.17
申请人 INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) ;UNIVERSITÉ PARIS DIDEROT - PARIS 7 ;ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) 发明人 POYET Jean-Luc;BRUZZONI-GIOVANELLI Heriberto;JAGOT-LACOUSSIERE Léonard
分类号 C07K14/47;C12N7/00;C07K14/005 主分类号 C07K14/47
代理机构 代理人
主权项 1. A polypeptide which comprises or consists of: i) an amino acid sequence ranging from a phenylalanine residue at position 380 to a leucine residue at position 384 in SEQ ID NO:1 or, ii) an amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO:1, or iii) an amino acid sequence which is a retro-inverso of the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO:1 or, iv) an amino acid sequence which is retro-inverso of the amino acid sequence having at least 70% of identity with the amino acid sequence ranging from the phenylalanine residue at position 380 to the leucine residue at position 384 in SEQ ID NO:1, wherein the polypeptide does not consist of the amino acid sequence SEQ ID NO:1 and does not consist of the amino acid sequence ranging from an alanine residue at position 363 to a threonine residue at position 399 in SEQ ID NO: 1.
地址 Paris FR